Options for Eyebrow and Eyelash Regrowth in a 32-Year-Old Female With Alopecia Areata
March 18th 2025An expert discusses a 32-year-old woman with alopecia areata affecting eyebrows/eyelashes. Treatment options include topical/intralesional steroids, minoxidil, prostaglandin analogues, JAK inhibitors, and cosmetic approaches.
Recapping the Evolving Treatment Landscape for Atopic Dermatitis
March 13th 2025The panelist discusses how the therapeutic options for atopic dermatitis have expanded significantly with the emergence of targeted biologics, oral agents, and refined topical treatments, transforming the management approach for patients across the disease spectrum.
Sunscreen Ingredients for UV and Visible Light Protection
March 12th 2025An expert discusses how UV radiation causes DNA damage, accelerating skin aging and cancer risk. Visible light and infrared radiation induce oxidative stress and hyperpigmentation, especially in darker skin tones. Conventional sunscreens shield against UV radiation but offer limited visible light and infrared protection. Mineral filters (zinc oxide, titanium dioxide) provide broad coverage, while chemical filters (oxybenzone, avobenzone) absorb UV radiation but lack efficacy against visible and infrared radiation.
The Solar Spectrum and Impact on Skin Health
March 12th 2025An expert discusses how UV radiation makes up about 7% of the sun’s energy and penetrates the skin, causing aging, hyperpigmentation, and inflammation. Visible light and infrared radiation contribute to skin damage, with blue light being more harmful than red light due to its deeper penetration.
Empowering the Eczema Community: NEA’s Vision for Support, Education, and Awareness
March 12th 2025Renata Block, MMS, PA-C, speaks with Wendy Smith Begolka, MBS, of the National Eczema Association about NEA’s strategic efforts in community outreach, health care provider engagement, and patient education.
Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers
March 11th 2025An expert discusses how alopecia areata significantly affects adolescent mental health. Treatment with ritlecitinib requires proper severity assessment via Severity of Alopecia Tool (SALT) score, clear communication of realistic timelines and goals, careful monitoring, and discussion of potential adverse effects. Long-term adherence is crucial for maintaining results.
Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata
March 11th 2025An expert discusses how treatment for this adolescent boy with severe alopecia areata must balance efficacy with age-appropriate safety, considering psychological impact, growth/development factors, and family preferences while selecting among topical, intralesional, systemic, or emerging biologic options.